Trichomoniasis and lactoferrin: Future prospects

Infectious Diseases in Obstetrics and Gynecology

Volumn 2012, Issue , 2012, Pages

  Sehgal, Rakesh ^a   Goyal, Kapil ^a   Sehgal, Alka ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CP65 CYSTEINE PROTEINASE; CYSTEINE PROTEINASE; FERRIC ION; FERROUS ION; IRON; LACTOFERRIN; LACTOFERRIN BINDING RECEPTOR; METRONIDAZOLE; P270 PROTEIN; PROTEINASE; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; RECEPTOR; TRICHOMONAS VAGINALIS VACCINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CHELATING AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTIPROTOZOAL ACTIVITY; CELL ADHESION; CLINICAL FEATURE; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; ENZYME DEGRADATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MENSTRUAL CYCLE; MICROBIAL GROWTH; NONHUMAN; PARASITE TRANSMISSION; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VACCINATION; VAGINA MUCOSA; ANIMAL; FEMALE; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ANIMALS; ANTI-INFECTIVE AGENTS; CHELATING AGENTS; FEMALE; HUMANS; IRON; LACTOFERRIN; MENSTRUAL CYCLE; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS;

EID: 84866939594     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2012/536037     Document Type: Review

References (63)

1. McClelland R. S., Trichomonas vaginalis infection: can we afford to do nothing? Journal of Infectious Diseases 2008 197 4 487 489 2-s2.0-40049089082 10.1086/526498
2. Petrin D., Delgaty K., Bhatt R., Garber G., Clinical and microbiological aspects of Trichomonas vaginalis. Clinical Microbiology Reviews 1998 11 2 300 317 2-s2.0-0031978286
3. Schwebke J. R., Burgess D., Trichomoniasis. Clinical Microbiology Reviews 2004 17 4 794 803 2-s2.0-5644250477 10.1128/CMR.17.4.794-803.2004
4. Heine P., McGregor J. A., Trichomonas vaginalis: a reemerging pathogen. Clinical Obstetrics and Gynecology 1993 36 1 137 144 2-s2.0-0027533322
5. Goswami T., Rolfs A., Hediger M. A., Iron transport: emerging roles in health and disease. Biochemistry and Cell Biology 2002 80 5 679 689 2-s2.0-0036968688 10.1139/o02-159
6. Weinberg E. D., Iron and susceptibility to infectious disease. Science 1974 184 4140 952 956 2-s2.0-0016227934
7. Vanacova S., Rasoloson D., Rázga J., Hrd I., Kulda J., Tachezy J., Iron-induced changes in pyruvate metabolism of Tritrichomonas foetus and involvement of iron in expression of hydrogenosomal proteins. Microbiology 2001 147 1 53 62 2-s2.0-0035148218
8. Schaible U. E., Kaufmann S. H. E., Iron and microbial infection. Nature Reviews Microbiology 2004 2 12 946 953 2-s2.0-10444232719 10.1038/nrmicro1046
9. Dunn L. L., Rahmanto Y. S., Richardson D. R., Iron uptake and metabolism in the new millennium. Trends in Cell Biology 2007 17 2 93 100 2-s2.0-33846691564 10.1016/j.tcb.2006.12.003
10. Zhang A. S., Enns C. A., Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. Journal of Biological Chemistry 2009 284 2 711 715 2-s2.0-59449109182 10.1074/jbc.R800017200
11. Baker E. N., Baker H. M., Molecular structure, binding properties and dynamics of lactoferrin. Cellular and Molecular Life Sciences 2005 62 22 2531 2539 2-s2.0-28344440468 10.1007/s00018-005-5368-9
12. Legrand D., Pierce A., Elass E., Carpentier M., Mariller C., Mazurier J., Lactoferrin structure and functions. Advances in Experimental Medicine and Biology 2008 606 163 194 2-s2.0-38349159843 10.1007/978-0-387-74087-4-6
13. Van Veen H. A., Geerts M. E. J., Van Berkel P. H. C., Nuijens J. H., The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis. European Journal of Biochemistry 2004 271 4 678 684 2-s2.0-1342322699 10.1111/j.1432-1033.2003.03965.x
14. Vorland L. H., Lactoferrin: a multifunctional glycoprotein. APMIS 1999 107 11 971 981 2-s2.0-0032737846
15. Lambert L. A., Molecular evolution of the transferrin family and associated receptors. Biochimica et Biophysica Acta 2012 1820 3 244 255 2-s2.0-54049106841 10.1016/j.bbagen.2011.06.002
16. Van der Strate B. W. A., Beljaars L., Molema G., Harmsen M. C., Meijer D. K. F., Antiviral activities of lactoferrin. Antiviral Research 2001 52 3 225 239 2-s2.0-0034773616 10.1016/S0166-3542(01)00195-4
17. Ward P. P., Paz E., Conneely O. M., Multifunctional roles of lactoferrin: a critical overview. Cellular and Molecular Life Sciences 2005 62 22 2540 2548 2-s2.0-28344447990 10.1007/s00018-005-5369-8
18. Bennett R. M., Kokocinski T., Lactoferrin content of peripheral blood cells. British Journal of Haematology 1978 39 4 509 521 2-s2.0-0018147096
19. Legrand D., Elass E., Carpentier M., Mazurier J., Lactoferrin: a modulator of immune and inflammatory responses. Cellular and Molecular Life Sciences 2005 62 22 2549 2559 2-s2.0-28444462150 10.1007/s00018-005-5370-2
20. Valenti P., Antonini G., Lactoferrin: an important host defence against microbial and viral attack. Cellular and Molecular Life Sciences 2005 62 22 2576 2587 2-s2.0-28344457682 10.1007/s00018-005-5372-0
21. Puddu P., Valenti P., Gessani S., Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 2009 91 1 11 18 2-s2.0-58149140244 10.1016/j.biochi.2008.05.005
22. Paesano R., Torcia F., Berlutti F., Pacifici E., Ebano V., Moscarini M., Valenti P., Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women. Biochemistry and Cell Biology 2006 84 3 377 380 2-s2.0-33748423889 10.1139/O06-040
23. Paesano R., Berlutti F., Pietropaoli M., Pantanella F., Pacifici E., Goolsbee W., Valenti P., Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women. BioMetals 2010 23 3 411 417 2-s2.0-77953249514 10.1007/s10534-010-9335-z
24. Paesano R., Pietropaoli M., Gessani S., Valenti P., The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia. Biochimie 2009 91 1 44 51 2-s2.0-58149105930 10.1016/j.biochi.2008.06.004
25. Puddu P., Latorre D., Carollo M., Catizone A., Ricci G., Valenti P., Gessani S., Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells. PLoS One 2011 6 7 2-s2.0-79960724573 10.1371/journal.pone.0022504 e22504
26. Berlutti F., Schippa S., Morea C., Sarli S., Perfetto B., Donnarumma G., Valenti P., Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochemistry and Cell Biology 2006 84 3 351 357 2-s2.0-33748418054 10.1139/O06-039
27. Valenti P., Catizone A., Pantanella F., Frioni A., Natalizi T., Tendini M., Berlutti F., Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm. International Journal of Immunopathology and Pharmacology 2011 24 4 1057 1068
28. Suzuki Y. A., Wong H., Ashida K. Y., Schryvers A. B., Lönnerdal B., The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus. Biochemistry 2008 47 41 10915 10920 2-s2.0-53749102295 10.1021/bi8012164
29. Bullen J. J., The significance of iron in infection. Reviews of Infectious Diseases 1981 3 6 1127 1138 2-s2.0-0019640696
30. Elass E., Masson M., Mazurier J., Legrand D., Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infection and Immunity 2002 70 4 1860 1866 2-s2.0-0036129834 10.1128/IAI.70.4.1860-1866.2002
31. León-Sicairos N., López-Soto F., Reyes-López M., Godínez-Vargas D., Ordaz-Pichardo C., De La Garza M., Amoebicidal activity of milk, apo-lactoferrin, slgA and lysozyme. Clinical Medicine and Research 2006 4 2 106 113 2-s2.0-33745930520 10.3121/cmr.4.2.106
32. Weinberg E. D., Iron availability and infection. Biochimica et Biophysica Acta 2009 1790 7 600 605 2-s2.0-70349923239 10.1016/j.bbagen.2008.07.002
33. Ortíz-Estrada G., Luna-Castro S., Piña-Vázquez C., Samaniego-Barrón L., León-Sicairos N., Serrano-Luna J., De La Garza M., Iron-saturated lactoferrin and pathogenic protozoa: could this protein be an iron source for their parasitic style of life? Future Microbiology 2012 7 1 149 164 2-s2.0-84555190766 10.2217/fmb.11.140
34. Weinberg E. D., Microbial pathogens with impaired ability to acquire host iron. BioMetals 2000 13 1 85 89 2-s2.0-0034105860 10.1023/A:1009293500209
35. Sutak R., Chamot C., Tachezy J., Camadro J. M., Lesuisse E., Siderophore and haem iron use by Tritrichomonas foetus. Microbiology 2004 150 12 3979 3987 2-s2.0-11044232246 10.1099/mic.0.27544-0
36. Peterson K. M., Alderete J. F., Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors. Journal of Experimental Medicine 1984 160 2 398 410 2-s2.0-0021211306
37. Lehker M. W., Chang T. H., Dailey D. C., Alderete J. F., Specific erythrocyte binding is an additional nutrient acquisition system for Trichomonas vaginalis. Journal of Experimental Medicine 1990 171 6 2165 2170 2-s2.0-0025354379 10.1084/jem.171.6.2165
38. Lehker M. W., Alderete J. F., Iron regulates growth of Trichomonas vaginalis and the expression of immunogenic trichomonad proteins. Molecular Microbiology 1992 6 1 123 132 2-s2.0-0026502193
39. Cohen M. S., Britigan B. E., French M., Bean K., Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. American Journal of Obstetrics and Gynecology 1987 157 5 1122 1125 2-s2.0-0023639356
40. Yuan Y. Q., Xue C. G., Influence of iron ion on the growth of Trichomonas vaginalis in vitro. Chinese Journal of Parasitology & Parasitic Diseases 2010 28 4 273 276 2-s2.0-84856014211
41. Alderete J. F., Benchimol M., Lehker M. W., Crouch M. L., The complex fibronectin Trichomonas vaginalis interactions and Trichomonosis. Parasitology International 2002 51 3 285 292 2-s2.0-0036756764 10.1016/S1383-5769(02)00015-6
42. Crouch M. L., Benchimol M., Alderete J. F., Binding of fibronectin by Trichomonas vaginalis is influenced by iron and calcium. Microbial Pathogenesis 2001 31 3 131 144 2-s2.0-0034866226 10.1006/mpat.2001.0455
43. Kucknoor A. S., Mundodi V., Alderete J. F., The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65. Cellular Microbiology 2007 9 11 2586 2597 2-s2.0-34848847880 10.1111/j.1462-5822.2007.00979.x
44. Hsu H. M., Ong S. J., Lee M. C., Tai J. H., Transcriptional regulation of an iron-inducible gene by differential and alternate promoter entries of multiple Myb proteins in the protozoan parasite Trichomonas vaginalis. Eukaryotic Cell 2009 8 3 362 372 2-s2.0-61949251703 10.1128/EC.00317-08
45. Gorrell T. E., Effect of culture medium iron content on the biochemical composition and metabolism of Trichomonas vaginalis. Journal of Bacteriology 1985 161 3 1228 1230 2-s2.0-0021951972
46. Moreno-Brito V., Yanez-Gomez C., Meza-Cervantez P., Avila-Gonzalez L., Rodríguez M. A., Ortega-López J., González-Robles A., Arroyo R., A Trichomonas vaginalis 120 kDa protein with identity to hydrogenosome pyruvate:ferredoxin oxidoreductase is a surface adhesin induced by iron. Cellular Microbiology 2005 7 2 245 258 2-s2.0-13844308104 10.1111/j.1462-5822.2004.00455.x
47. Harp D. F., Chowdhury I., Trichomoniasis: evaluation to execution. European Journal of Obstetrics Gynecology and Reproductive Biology 2011 157 1 3 9 2-s2.0-65249134500 10.1016/j.ejogrb.2011.02.024
48. Lama A., Kucknoor A., Mundodi V., Alderete J. F., Glyceraldehyde-3- phosphate dehydrogenase is a surface-associated, fibronectin-binding protein of Trichomonas vaginalis. Infection and Immunity 2009 77 7 2703 2711 2-s2.0-67650032436 10.1128/IAI.00157-09
49. Tsai C. D., Liu H. W., Tai J. H., Characterization of an iron-responsive promoter in the protozoan pathogen Trichomonas vaginalis. Journal of Biological Chemistry 2002 277 7 5153 5162 2-s2.0-0037085285 10.1074/jbc.M110234200
50. Ryu J. S., Choi H. K., Min D. Y., Ha S. E., Ahn M. H., Effect of iron on the virulence of Trichomonas vaginalis. Journal of Parasitology 2001 87 2 457 460 2-s2.0-0035052105
51. Alderete J. F., Provenzano D., Lehker M. W., Iron mediates Trichomonas vaginalis resistance to complement lysis. Microbial Pathogenesis 1995 19 2 93 103 2-s2.0-0028827837 10.1006/mpat.1995.0049
52. Wang A. L., Wang C. C., The double-stranded RNA in Trichomonas vaginalis may originate from virus-like particles. Proceedings of the National Academy of Sciences of the United States of America 1986 83 20 7956 7960 2-s2.0-0023038689
53. Wang A., Wang C. C., Alderete J. F., Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus. Journal of Experimental Medicine 1987 166 1 142 150 2-s2.0-0023215826
54. Alderete J. F., Iron modulates phenotypic variation and phosphorylation of P270 in double-stranded RNA virus-infected Trichomonas vaginalis. Infection and Immunity 1999 67 8 4298 4302 2-s2.0-0032765417
55. Lehker M. W., Arroyo R., Alderete J. F., The regulation by iron of the synthesis of adhesins and cytoadherence levels in the protozoan Trichomonas vaginalis. Journal of Experimental Medicine 1991 174 2 311 318 2-s2.0-0025766755
56. Garcia A. F., Chang T. H., Benchimol M., Klumpp D. J., Lehker M. W., Alderete J. F., Iron and contact with host cells induce expression of adhesins on surface of Trichomonas vaginalis. Molecular Microbiology 2003 47 5 1207 1224 2-s2.0-0037338699 10.1046/j.1365-2958.2003.03366.x
57. Alvarez-Sánchez M. E., Solano-González E., Yañez-Gómez C., Arroyo R., Negative iron regulation of the CP65 cysteine proteinase cytotoxicity in Trichomonas vaginalis. Microbes and Infection 2007 9 14-15 1597 1605 2-s2.0-36849079342 10.1016/j.micinf.2007.09.011
58. Hernandez-Gutierrez R., Ortega-López J., Arroyo R., A 39-kDa cysteine proteinase CP39 from Trichomonas vaginalis, which is negatively affected by iron may be involved in Trichomonal Cytotoxicity. Journal of Eukaryotic Microbiology 2003 50 696 698 2-s2.0-0347596971 10.1111/j.1550-7408. 2003.tb00692.x
59. León-Sicairos C. R., León-Félix J., Arroyo R., Tvcp12: a novel Trichomonas vaginalis cathepsin L-like cysteine proteinase-encoding gene. Microbiology 2004 150 5 1131 1138 2-s2.0-2942560496
60. Crouch M. L. V., Alderete J. F., Trichomonas vaginalis has two fibronectin-like iron-regulated genes. Archives of Medical Research 2001 32 2 102 107 2-s2.0-0035024050 10.1016/S0188-4409(01)00262-4
61. Robinson S. C., Trichomonal Vaginitis Resistant to Metranidazole. Canadian Medical Association Journal 1962 86 665
62. Dunne R. L., Dunn L. A., Upcroft P., O'Donoghue P. J., Upcroft J. A., Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Research 2003 13 4 239 249 2-s2.0-1542572794 10.1038/sj.cr.7290169
63. Upcroft P., Upcroft J. A., Drug targets and mechanisms of resistance in the anaerobic protozoa. Clinical Microbiology Reviews 2001 14 1 150 164 2-s2.0-0035138734 10.1128/CMR.14.1.150-164.2001